Allogeneic CD7 CAR γδ T Cells Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic CD7 CAR γδ T Cells Therapy, covering 2025-08-13 to 2025-08-13. Get the full timeline:
Most recent: Clinical Trial Update: Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia [Phase 1]